INTERNATIONAL PATENT: DERMIRA, INC. FILES APPLICATION FOR "IL-13 ANTIBODIES FOR THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS"

GENEVA, June 25 -- DERMIRA, INC. (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2024/060022) for "IL-13 ANTIBODIES FOR THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS" on Dec 13, 2024. With publication no. WO/2025/128990, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BIRT, Julie Alison (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), DEARDORFF, Lynn Marie (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), NATALIE, Chitra Rao (c/o Eli Lil...